Comprehensive Introduction to Myocardial Strain Imaging (GLS)
Myocardial Strain Imaging, specifically Global Longitudinal Strain (GLS), represents a paradigm shift in the field of echocardiography. While traditional echocardiography relies heavily on Left Ventricular Ejection Fraction (LVEF) to assess cardiac function, GLS provides a more nuanced, sensitive, and objective measurement of myocardial deformation.
At its core, GLS measures the percentage of shortening of the myocardium in the longitudinal direction during systole. It is a derivative of Speckle Tracking Echocardiography (STE), a technology that tracks the movement of natural acoustic markers (speckles) within the heart muscle across the cardiac cycle. By analyzing these speckles, clinicians can detect subclinical myocardial dysfunction long before the LVEF drops below the normal range, making it an indispensable tool for early diagnosis and prognostic stratification.
Technical Specifications and Mechanisms
Understanding the physics of GLS requires a grasp of cardiac mechanics. The heart muscle consists of fibers arranged in complex orientations, allowing for shortening, thickening, and rotation.
The Mechanism of Speckle Tracking
Speckle tracking is independent of the Doppler effect. The ultrasound machine identifies small "speckles" created by the interference of ultrasound waves with the myocardial tissue. These speckles are tracked frame-by-frame throughout the cardiac cycle.
- Longitudinal Strain: Measures the shortening of the heart from base to apex.
- Circumferential Strain: Measures the shortening along the circumference of the ventricle.
- Radial Strain: Measures the thickening of the myocardium toward the center of the cavity.
GLS is specifically the average of the longitudinal strain values of the 17 segments of the left ventricle, as defined by the American Society of Echocardiography (ASE).
Technical Requirements
| Specification | Detail |
|---|---|
| Frame Rate | Optimal between 50–90 frames per second |
| View Acquisition | Apical 4-chamber, 2-chamber, and 3-chamber views |
| Software | Specialized speckle-tracking software (e.g., GE, Philips, Siemens) |
| Image Quality | Requires high-resolution 2D grayscale images |
Extensive Clinical Indications and Usage
The clinical utility of GLS spans various cardiovascular conditions. Its ability to detect "silent" myocardial damage makes it a frontline tool in modern cardiology.
1. Cardio-Oncology
This is arguably the most critical application of GLS. Patients undergoing cardiotoxic chemotherapy (such as anthracyclines or HER2-targeted therapies) are at risk of heart failure. A relative decrease in GLS of >15% is often used as a marker for early intervention, even when LVEF remains normal.
2. Heart Failure with Preserved Ejection Fraction (HFpEF)
Many patients with symptoms of heart failure have a normal LVEF. GLS often reveals occult systolic dysfunction in these patients, helping to confirm the diagnosis and guide management.
3. Valvular Heart Disease
In conditions like aortic stenosis or mitral regurgitation, GLS helps determine the optimal timing for surgical intervention. A decline in GLS can indicate early myocardial decompensation despite a preserved ejection fraction.
4. Hypertrophic Cardiomyopathy (HCM)
GLS can differentiate between physiological hypertrophy (athlete’s heart) and pathological hypertrophy, as well as identify areas of fibrosis or early remodeling.
5. Amyloidosis
GLS shows a characteristic "apical sparing" pattern—where the apex of the heart retains strain while the base shows significantly reduced strain. This is a highly specific diagnostic indicator for cardiac amyloidosis.
Patient Preparation and Procedure Steps
Preparation for a GLS-enhanced echocardiogram is identical to a standard transthoracic echocardiogram (TTE).
Patient Preparation
- Fasting: Usually not required, unless combined with other procedures.
- Clothing: Patients will be asked to wear a hospital gown.
- History: Provide the sonographer with a list of current medications, especially if on heart rate control or chemotherapy.
The Procedural Workflow
- Patient Positioning: The patient is placed in the left lateral decubitus position.
- Image Acquisition: The sonographer acquires high-quality 2D loops of the apical 4, 2, and 3-chamber views. The images must be stable and free of significant artifacts.
- Endocardial Border Tracing: The software automatically identifies the endocardial border. The clinician must manually adjust this trace to ensure it follows the myocardium accurately.
- Verification: The software tracks the speckles throughout the cardiac cycle. The technician verifies that the tracking is accurate across all segments.
- Data Generation: The system calculates the GLS value (%) and generates a "Bull's Eye" plot representing the strain in each segment.
Risks, Side Effects, and Contraindications
Myocardial Strain Imaging is performed via standard transthoracic ultrasound. It is a non-invasive, non-ionizing, and highly safe procedure.
- Radiation Exposure: Zero. Unlike CT or Nuclear Medicine scans, echocardiography uses sound waves.
- Side Effects: Minimal. Some patients may experience minor skin irritation from the ultrasound gel.
- Contraindications: There are no absolute contraindications. However, if a patient has poor acoustic windows (e.g., due to severe emphysema or obesity), the accuracy of speckle tracking may be compromised, leading to unreliable results.
Interpretation: Normal vs. Abnormal Results
Strain is typically expressed as a negative percentage (e.g., -20%). This is because the myocardium shortens (contracts) during systole.
Normal Reference Ranges
While ranges can vary based on the software vendor and age, the general consensus for a normal GLS is:
* Normal: -18% to -22%
* Borderline: -16% to -18%
* Abnormal: > -16% (meaning less negative, indicating reduced function)
Interpreting the Bull's Eye Plot
The Bull's Eye plot provides a visual representation of regional function.
* Red/Darker Colors: Indicate healthy, high-strain segments.
* Pink/White/Grey: Indicate reduced or absent strain, suggesting ischemia, infarction, or infiltration.
Frequently Asked Questions (FAQ)
1. Is GLS the same as an Ejection Fraction (EF)?
No. EF measures the volume of blood pumped out of the ventricle. GLS measures the actual deformation (shortening) of the heart muscle fibers themselves.
2. Why is my GLS result negative?
A negative value is normal. It indicates that the heart muscle is shortening (contracting) during systole. A "lower" number (e.g., -15%) indicates worse function than a "higher" number (e.g., -20%).
3. Does GLS require contrast dye?
Generally, no. GLS is performed on standard 2D grayscale images. Contrast is only used if the endocardial borders are not clearly visible.
4. How long does the procedure take?
The acquisition of the GLS images typically adds only 5 to 10 minutes to a standard echocardiogram.
5. Can GLS detect heart attacks?
Yes, GLS can identify regional wall motion abnormalities that are characteristic of past or current myocardial infarction, often with higher sensitivity than visual assessment alone.
6. Is this procedure covered by insurance?
Most insurance providers cover GLS when it is deemed medically necessary, especially in the context of cancer treatment or heart failure management.
7. Does the machine type matter?
Yes. Because software algorithms differ between manufacturers, it is recommended to perform follow-up scans on the same machine/vendor whenever possible to ensure consistency.
8. Can GLS be used in children?
Yes, it is increasingly used in pediatric cardiology, particularly to monitor patients with congenital heart disease or those receiving chemotherapy.
9. What should I do if my GLS is abnormal?
An abnormal GLS is a clinical finding, not a diagnosis. Your cardiologist will correlate this result with your physical symptoms, blood work (like NT-proBNP), and other imaging modalities to determine the next steps.
10. How often should I have this test?
The frequency depends on your clinical condition. Cardio-oncology patients may have it performed every cycle of chemotherapy, while others may have it performed annually or biennially.
Conclusion
Myocardial Strain Imaging (GLS) has revolutionized the way we assess the heart. By moving beyond the volumetric limitations of the Ejection Fraction, clinicians can now identify the earliest signs of myocardial stress and dysfunction. Whether it is protecting the hearts of cancer patients or fine-tuning the management of heart failure, GLS stands as a cornerstone of high-precision, evidence-based cardiology. If you have been referred for this scan, you are receiving the gold standard in functional cardiac assessment.